Aktie RMDA TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.

Aktien

RMDA

EGS381B1C015

RMDA

Schlusskurs Egyptian Exchange
Andere Börsenplätze
 00:00:00 02.05.2024 		% 5 Tage % 1. Jan.
2.07 EGP +0.49% Intraday Chart für Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. -6.76% +25.45%
19.03. Zehnter Ramadan für Pharmazeutische Industrien und Diagnostische Reagenzien (Rameda) S.A.E. meldet Ergebnis für das Gesamtjahr bis zum 31. Dezember 2023 CI
2023 Zehnter Ramadan für Pharmazeutische Industrien und Diagnostische Reagenzien (Rameda) S.A.E. meldet Ergebniszahlen für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) dropped from EGX 30 Index
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Ekuity B.V. acquired additional 5.38% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for approximately EGP 160 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. announces an Equity Buyback for 10% of its issued share capital.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. authorizes a buyback plan.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
The Saudi Seventh Investment Company agreed to acquire additional 6.5% stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for GGP 135 million.
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) - Listing Committee Decision
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda E : Pharmaceutical Industries & Diagnostic - Rameda (RMDA.CA) Reports Year Ended 31/12/2021 Consolidated Results
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E.(CASE:RMDA) added to EGX 30 Index
Equinox Pharma Holding Ltd. acquired additional 2.71% minority stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. for EGP 58.3 million.
STenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents S.A.E. Announce Audited Consolidated Earnings Results for the Quarter Ended March 31, 2021
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Reports Earnings Results for the Full Year Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. RMDA Aktie
  4. Nachrichten Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
  5. Andere Sprachen